-
3 Cardiovascular and CNS Leader, Chronic Therapy Specialist and Largest Domestic Pharma Seller Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Eris Lifesciences and Mankind Pharma
- October 26, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
No Comments
Branded Prescription Drug Maker Stocks with a strong future roadmap: Torrent Pharmaceuticals, Eris Lifesciences and Mankind Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Specialty Branded Generics, Global Generics and Injectables and Cardiac Therapy Leader Stocks With a Strong Future Roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals
- October 23, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Branded Generic and Global Formulation Stocks with a strong future roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.
-
3 Specialty Export Formulations, Cardiac and CNS Leader and Contract Injectables Stocks With a Strong Future Roadmap: Rubicon Research, Torrent Pharmaceuticals and Gland Pharma
- October 22, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Pharma Exports and Chronic Care Stocks with a strong future roadmap: Rubicon Research, Torrent Pharmaceuticals and Gland Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Acute Therapy Franchise, Chronic Care Leader and Regulated Market Generics Stocks With a Strong Future Roadmap: Alkem Laboratories, Torrent Pharmaceuticals and Strides Pharma Science
- October 21, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Pharma Franchise Stocks with a strong future roadmap: Alkem Laboratories, Torrent Pharmaceuticals and Strides Pharma Science. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Cardiac Brands, Pain Care Portfolio and Custom Synthesis Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories
- October 21, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Pharma Brand and Ingredient Stocks with a strong future roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
- 1
- 2